Cardiac injury in COVID-19
COVID-19 is a multisystem disease, and cardiac injury has been identified as a major contributor to the pathology. Antoine Vieillard-Baron is an intensivist and researcher from Boulogne in France, and he joins the podcast to talk about key echocardiographic patterns of disease found in COVID-19
Vaccine induced thrombotic thrombocytopenia
As the world wrestles with the COVID-19 pandemic, it’s clear that much depends on our ability to vaccinate a large proportion of the population. Like all medications, vaccines have their side effects, and the most notable at present is an unusual syndrome of intravascular clotting associated with …
Covid nutrition
Despite the incredible burden of COVID-19, ICU researchers have somehow been able to produce practice changing research at an unprecedented rate. ICU nutrition researchers Lee-anne Chapple and Emma Ridley join Todd on the podcast to discuss their findings regarding the nutritional status and issue…
SPRINT SARI - an update
Aidan Burrell joins the podcast to update our listeners with the progress of the SPRINT SARI project - designed to collect real time data on the COVID-19 pandemic in Australasia.
Long term outcomes from COVID
COVID 19 has ravaged many parts of the world, leaving some patients with persistent symptoms known as "Long COVID". But what about survivors of critical illness due to COVID-19? How do they compare with other ICU survivors? Professor Carol Hodgson is the Head of the Division of Clinical Trials a…
Lise Estcourt - convalescent plasma in COVID 19
As the COVID-19 pandemic continues unabated, the search for meaningful therapies is being led by clinical researchers. Dr Lise Estcourt is a consultant haematologist who has led major studies into the role of convalescent plasma in the treatment of COVID-19. She joins Todd on the podcast to summa…
Colin McArthur - REMAP-CAP steroids
Colin McArthur is an Intensivist and director of research at Auckland City Hospital in New Zealand, and is the Co-lead for the Australia-New Zealand arm of the REMAP-CAP study, which today releases the results of its first domain study, corticosteroids. Colin joins Todd on the podcast to discuss t…
Tony Gordon - convalescent serum for COVID-19
As the COVID-19 pandemic surges ahead, researchers are desperately seeking evidence to support a range of potential disease modifying treatments. On this episode, Prof Tony Gordon from Imperial Hospitals in London joins me to discuss one such potential therapy, convalescent serum. Tony is a prom…
Colin McArthur - Hydroxychloroquine in COVID-19
The unfolding COVID-19 pandemic has seen an unprecedented sharing of information to support clinicians in making clinical decisions at the coal-face. But has this pressure to publish data come at the cost of lower standards of governance? Colin McArthur, co-lead of the ANZ arm of the REMAP-CAP st…
Mark Nichols - ANZICS COVID19 guidelines update
As the COVID-19 outbreak unfolds, increasing experience with the disease has allowed much to be learned. Dr Mark Nichols joins Todd on the podcast to discuss the updated COVID-19 guidelines from the Australia-New Zealand Intensive Care Society (ANZICS).